B7–H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors

B7–H3 (CD276), a member of the B7 superfamily, is an important factor in downregulating immune responses against tumors. It is also aberrantly expressed in many human malignancies. Beyond immune regulatory roles, its overexpression has been linked to invasive metastatic potential and poor prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Maachani, Uday B., Tosi, Umberto, Pisapia, David J., Mukherjee, Sushmita, Marnell, Christopher S., Voronina, Julia, Martinez, Daniel, Santi, Mariarita, Dahmane, Nadia, Zhou, Zhiping, Hawkins, Cynthia, Souweidane, Mark M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938869/
https://www.ncbi.nlm.nih.gov/pubmed/31887631
http://dx.doi.org/10.1016/j.tranon.2019.11.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938869/
https://www.ncbi.nlm.nih.gov/pubmed/31887631
http://dx.doi.org/10.1016/j.tranon.2019.11.006

Ejemplares similares